{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:40:25Z","timestamp":1791178825625,"version":"4.1.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This meta-analysis aims to evaluate the efficacy and safety of autologous platelet-rich plasma (PRP) administration in reducing adhesion recurrence and improving pregnancy outcomes in patients with intrauterine adhesion (IUA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a comprehensive search of Pubmed, Embase, the Cochrane Library, Web of Science, Scopus, and China National Knowledge Internet (CNKI) from inception to February 10, 2023, without any language or regional restrictions. We used random-effects models to assess odds ratios (OR) and weight mean differences (WMD) with 95% confidence intervals (CI).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our meta-analysis included a total of 730 patients from 10 clinical studies (6 RCTs and 4 non-RCTs). The results showed that PRP administration significantly increased endometrial thickness (WMD = 0.79, 95% CI: 0.40\u20131.19; P &amp;lt; 0.001; I<jats:sup>2<\/jats:sup> = 0.0%), menstrual volume (WMD = 2.96, 95% CI = 2.30\u20133.61; P &amp;lt; 0.001; I<jats:sup>2<\/jats:sup> = 0.0%), and days of menstruation (WMD = 1.13, 95% CI = 0.86\u20131.41; P &amp;lt; 0.001; I<jats:sup>2<\/jats:sup> = 0.0%). Additionally, the clinical pregnancy rate was also improved (OR = 1.82, 95% CI: 1.19-2.78; P = 0.006; I<jats:sup>2<\/jats:sup> = 0.0%). However, there was insufficient evidence to reach a conclusion regarding the effects of PRP on the recurrence rate of moderate to severe IUA, changes in AFS scores, miscarriage rate, and live birth rate.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our analysis confirms that autologous PRP is an effective treatment for IUA. However, the limited sample size suggests that the results should be interpreted with caution. Therefore, larger and well-designed studies are necessary in the future to confirm these findings and explore the optimal PRP dosing regimens further.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p><jats:uri>https:\/\/www.crd.york.ac.uk\/PROSPERO<\/jats:uri>, identifier CRD42023391115.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1183209","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T22:15:56Z","timestamp":1688681756000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Clinical evaluation of autologous platelet-rich plasma therapy for intrauterine adhesions: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"14","author":[{"given":"Ruonan","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xifeng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daner","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(66)90452-2","article-title":"The pathology of postcurettage intrauterine adhesions","volume":"96","author":"Foix","year":"1966","journal-title":"Am J Obstet Gynecol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.02.096","article-title":"Asherman syndrome\u2013one century later","volume":"89","author":"Yu","year":"2008","journal-title":"Fertil Steril"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmt045","article-title":"Systematic review and meta-analysis of intrauterine adhesions after miscarriage: prevalence, risk factors and long-term reproductive outcome","volume":"20","author":"Hooker","year":"2014","journal-title":"Hum Reprod Update"},{"key":"B4","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.jmig.2016.11.008","article-title":"AAGL practice report: practice guidelines on intrauterine adhesions developed in collaboration with the European society of gynaecological endoscopy (ESGE)","volume":"24","year":"2017","journal-title":"J Minim Invasive Gynecol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"5175","DOI":"10.3390\/ijms22105175","article-title":"Focus on the primary prevention of intrauterine adhesions: current concept and vision","volume":"22","author":"Lee","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2007.03.070","article-title":"Factors affecting reproductive outcome of hysteroscopic adhesiolysis for asherman\u2019s syndrome","volume":"89","author":"Yu","year":"2008","journal-title":"Fertil Steril"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-009-1117-x","article-title":"Reproductive outcome following hysteroscopic adhesiolysis in patients with infertility due to asherman\u2019s syndrome","volume":"281","author":"Roy","year":"2010","journal-title":"Arch Gynecol Obstet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jmig.2013.07.018","article-title":"Efficacy of estrogen therapy in patients with intrauterine adhesions: systematic review","volume":"21","author":"Johary","year":"2014","journal-title":"J Minim Invasive Gynecol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2022.05.006","article-title":"Short- and long-term outcomes of postoperative intrauterine application of hyaluronic acid gel: a meta-analysis of randomized controlled trials","volume":"29","author":"Dou","year":"2022","journal-title":"J Minim Invasive Gynecol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0020-7292(03)00030-4","article-title":"A comparison of two adjunctive treatments for intrauterine adhesions following lysis","volume":"82","author":"Orhue","year":"2003","journal-title":"Int J Gynaecol Obstet"},{"key":"B11","first-page":"3S","article-title":"Growth factor content in PRP and their applicability in medicine","volume":"26","author":"Lubkowska","year":"2012","journal-title":"J Biol Regul Homeost Agents"},{"key":"B12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cytogfr.2021.11.003","article-title":"Applications of the regenerative capacity of platelets in modern medicine","volume":"64","author":"Cecerska-Heryc","year":"2022","journal-title":"Cytokine Growth Factor Rev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/jog.14964","article-title":"Efficacy and safety of autologous platelet-rich fibrin for the treatment of infertility with intrauterine adhesions","volume":"47","author":"Wang","year":"2021","journal-title":"J Obstet Gynaecol Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-021-02328-5","article-title":"Autologous platelet-rich plasma treatment for moderate-severe asherman syndrome: the first experience","volume":"38","author":"Aghajanova","year":"2021","journal-title":"J Assist Reprod Genet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20210289","article-title":"Ahmed. platelet rich plasma following hysteroscopic adhesolysis: a randomized clinical trial","volume":"10","author":"Mortada","year":"2021","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.12816\/0046137","article-title":"The value of using platelet rich plasma after hysteroscopic analysis of severe intrauterine adhesions (A randomized controlled trial)","volume":"71","author":"Amer MIM","year":"2018","journal-title":"Egypt J Hosp Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.21608\/ebwhj.2020.27971.1087","article-title":"Intrauterine use of autologous platelet-rich plasma in management of asherman syndrome: a randomized controlled trial","volume":"11","author":"Amer M","year":"2021","journal-title":"Evid Based Womens Health J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.3390\/jcm12041319","article-title":"Platelet-rich plasma improves pregnancy outcomes in moderate to severe intrauterine adhesion: a retrospective cohort study","volume":"12","author":"Qiu","year":"2023","journal-title":"J Clin Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.18502\/ijrm.v18i2.6423","article-title":"Platelet-rich plasma in the management of asherman\u2019s syndrome: an RCT","volume":"18","author":"Javaheri","year":"2020","journal-title":"Int J Reprod Biomed"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1674-9308.2021.28.040","article-title":"Clinical outcome analysis of platelet-rich plasma (PRP) in treating intrauterine adhesions (IUAs)","volume":"13","author":"Peng","year":"2021","journal-title":"China Continuing Med Education"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2022.07.003","article-title":"Efficacy of autologous platelet-rich plasma in preventing adhesion reformation following hysteroscopic adhesiolysis: a randomized controlled trial","volume":"45","author":"Shen","year":"2022","journal-title":"Reprod BioMed"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.26442\/20795696.2021.3.200878","article-title":"Possibilities of using platelet-rich autoplasm in the complex treatment of patients with intrauterine synechiae","volume":"23","author":"Martynov","year":"2021","journal-title":"Gynecology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"B28","article-title":"Autologous platelet-rich plasma promotes endometrial growth and improves pregnancy outcome during in vitro fertilization","volume":"8","author":"Chang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-018-1135-3","article-title":"Platelet-rich plasma in the management of asherman syndrome: case report","volume":"35","author":"Aghajanova","year":"2018","journal-title":"J Assist Reprod Genet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ejogrb.2022.01.030","article-title":"Value of intrauterine platelet-rich concentrates in patients with intrauterine adhesions after hysteroscopy: a systematic review and meta-analysis of randomized controlled trials","volume":"271","author":"Korany","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2005.07.008","article-title":"Platelet-rich fibrin (PRF): a second-generation platelet concentrate. part I: technological concepts and evolution","volume":"101","author":"Dohan","year":"2006","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2005.07.009","article-title":"Platelet-rich fibrin (PRF): a second-generation platelet concentrate. part II: platelet-related biologic features","volume":"101","author":"Dohan","year":"2006","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1089\/wound.2014.0581","article-title":"Metalloproteinases and wound healing","volume":"4","author":"Caley","year":"2015","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-018-1130-8","article-title":"In vitro evidence that platelet-rich plasma stimulates cellular processes involved in endometrial regeneration","volume":"35","author":"Aghajanova","year":"2018","journal-title":"J Assist Reprod Genet"},{"key":"B35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12958-017-0234-9","article-title":"Expression of SOX2, NANOG and OCT4 in a mouse model of lipopolysaccharide-induced acute uterine injury and intrauterine adhesions","volume":"15","author":"Xiao","year":"2017","journal-title":"Reprod Biol Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-012-0193-y","article-title":"Platelets in inflammation and immune modulations: functions beyond hemostasis","volume":"60","author":"Huang","year":"2012","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2741\/4613","article-title":"The biology of the platelet with special reference to inflammation, wound healing and immunity","volume":"23","author":"Nurden","year":"2018","journal-title":"Front Biosci (Landmark Ed)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2017.58.6.1195","article-title":"Effects of autologous platelet-rich plasma on regeneration of damaged endometrium in female rats","volume":"58","author":"Jang","year":"2017","journal-title":"Yonsei Med J"},{"key":"B39","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.xfss.2021.03.002","article-title":"A comparative evaluation of subendometrial and intrauterine platelet-rich plasma treatment for women with recurrent implantation failure","volume":"2","author":"Noushin","year":"2021","journal-title":"F S Sci"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1183209\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T22:24:04Z","timestamp":1688682244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1183209\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,6]]},"references-count":39,"alternative-id":["10.3389\/fendo.2023.1183209"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1183209","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,6]]},"article-number":"1183209"}}